CAPTRUST Financial Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.22M | Buy |
35,597
+8,868
| +33% | +$814K | 0.01% | 967 |
|
|
2025
Q4 | $2.4M | Sell |
26,729
-3,200
| -11% | -$303K | ﹤0.01% | 997 |
|
|
2025
Q3 | $2.95M | Sell |
29,929
-3,329
| -10% | -$330K | 0.01% | 848 |
|
|
2025
Q2 | $3.03M | Buy |
33,258
+6,068
| +22% | +$587K | 0.01% | 793 |
|
|
2025
Q1 | $3.08M | Sell |
27,190
-4,605
| -14% | -$493K | 0.01% | 734 |
|
|
2024
Q4 | $3.36M | Sell |
31,795
-1,919
| -6% | -$206K | 0.01% | 663 |
|
|
2024
Q3 | $3.64M | Sell |
33,714
-4,901
| -13% | -$535K | 0.01% | 620 |
|
|
2024
Q2 | $4.19M | Sell |
38,615
-116
| -0.3% | -$13.7K | 0.01% | 547 |
|
|
2024
Q1 | $5.11M | Sell |
38,731
-9,889
| -20% | -$1.24M | 0.02% | 492 |
|
|
2023
Q4 | $5.92M | Buy |
48,620
+638
| +1% | +$71.2K | 0.02% | 495 |
|
|
2023
Q3 | $5.38M | Sell |
47,982
-1,619
| -3% | -$206K | 0.02% | 492 |
|
|
2023
Q2 | $7.22M | Sell |
49,601
-5,054
| -9% | -$687K | 0.03% | 392 |
|
|
2023
Q1 | $7.06M | Buy |
54,655
+1,427
| +3% | +$179K | 0.03% | 367 |
|
|
2022
Q4 | $6.79M | Buy |
53,228
+380
| +0.7% | +$44.1K | 0.03% | 373 |
|
|
2022
Q3 | $5.53M | Buy |
52,848
+232
| +0.4% | +$25.5K | 0.03% | 375 |
|
|
2022
Q2 | $5.54M | Buy |
52,616
+2,160
| +4% | +$256K | 0.04% | 351 |
|
|
2022
Q1 | $6.46M | Buy |
50,456
+1,682
| +3% | +$203K | 0.04% | 310 |
|
|
2021
Q4 | $6.03M | Sell |
48,774
-3,858
| -7% | -$505K | 0.04% | 323 |
|
|
2021
Q3 | $7.49M | Buy |
52,632
+899
| +2% | +$132K | 0.06% | 256 |
|
|
2021
Q2 | $8.09M | Sell |
51,733
-1,146
| -2% | -$186K | 0.08% | 227 |
|
|
2021
Q1 | $8.23M | Buy |
52,879
+2,879
| +6% | +$446K | 0.09% | 207 |
|
|
2020
Q4 | $7.49M | Buy |
50,000
+1,531
| +3% | +$216K | 0.1% | 191 |
|
|
2020
Q3 | $6.47M | Sell |
48,469
-2,747
| -5% | -$359K | 0.11% | 185 |
|
|
2020
Q2 | $5.95M | Sell |
51,216
-141,017
| -73% | -$16.2M | 0.1% | 201 |
|
|
2020
Q1 | $16.8M | Buy |
192,233
+131,787
| +218% | +$17.3M | 0.37% | 70 |
|
|
2019
Q4 | $8.77M | Buy |
60,446
+39,571
| +190% | +$5.46M | 0.14% | 159 |
|
|
2019
Q3 | $2.79M | Sell |
20,875
-354
| -2% | -$45.7K | 0.1% | 181 |
|
|
2019
Q2 | $2.43M | Sell |
21,229
-165
| -0.8% | -$19.3K | 0.09% | 192 |
|
|
2019
Q1 | $2.66M | Buy |
21,394
+1,433
| +7% | +$163K | 0.11% | 160 |
|
|
2018
Q4 | $2.02M | Sell |
19,961
-114
| -0.6% | -$12.8K | 0.11% | 146 |
|
|
2018
Q3 | $2.56M | Buy |
20,075
+19,595
| +4,082% | +$2.33M | 0.11% | 124 |
|
|
2018
Q2 | $52K | Buy |
480
+269
| +127% | +$29.3K | ﹤0.01% | 669 |
|
|
2018
Q1 | $22K | Sell |
211
-5,132
| -96% | -$596K | ﹤0.01% | 805 |
|
|
2017
Q4 | $627K | Buy |
+5,343
| New | +$604K | 0.04% | 216 |
|
Other funds holding ZBH
VCM
VPM
CAPTRUST Financial Advisors's ZBH Position: Q1 2026 in Review
CAPTRUST Financial Advisors increased its Zimmer Biomet (ZBH) stake by 33% in Q1 2026, buying an estimated $814K and bringing the position to 35,597 shares worth $3.22M. The position accounts for 0.01% of the portfolio, ranked #967.
CAPTRUST Financial Advisors first reported a position in ZBH in Q4 2017 and has held it in 34 quarters since. The position peaked at $16.8M in Q1 2020. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- CAPTRUST Financial Advisors held 35,597 shares of Zimmer Biomet worth $3.22M as of Q1 2026.
- CAPTRUST Financial Advisors bought 8,868 Zimmer Biomet shares in Q1 2026, an estimated $814K.
- Zimmer Biomet made up 0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #967 holding.
- CAPTRUST Financial Advisors first reported a position in Zimmer Biomet in Q4 2017 and has held it in 34 quarters since.
- CAPTRUST Financial Advisors's Zimmer Biomet position peaked at $16.8M in Q1 2020.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.